Immunoscript was delighted to participate in INDIA-CEPI Sangam 2026, held in Delhi on 8th September, co-hosted by DBT, Government of India, BIRAC and CEPI. “Sangam,” meaning confluence, reflected the coming together of India’s scientific and manufacturing strengths with global partnerships to advance next-generation biologics, preparedness and equitable access. The event offered an opportunity to share Immunoscript’s perspectives and connect with partners across the vaccine ecosystem.